首页> 中文期刊> 《中国肺癌杂志》 >肺楔形切除术及纵隔淋巴结采样治疗早期高龄肺癌患者的体会

肺楔形切除术及纵隔淋巴结采样治疗早期高龄肺癌患者的体会

         

摘要

Background and objective The treatment for early-stage non-small cell lung cancer is primarily surgical. However, the optimal extent of mediastinal lymph node resection remains to be determined. The aim of the current study is to investigate the effect of a pulmonary wedge resection on aged patients with lung cancer. Methods A total of 15 lung cancer patients aged over 70 years were treated via video-assisted thoracoscopic surgery (VATS) wedge resection and mediastinal lymph node sampling from June 2004 to February 2008. Mediastinal lymph node sampling included stations 2R, 4R, 8 and 9 for the right-sided cancers and stations 5, 6,8 and 9 for the left-sided cancers. Results VATS wedge resection and mediastinal lymph node sampling for aged patients with peripheral lung cancer are minimally invasive treatments with a short operative time and low postoperative morbidity. The 1-year and 3-year survival rates were 100% and 86.6%, respectively. Conclusion VATS wedge resection and mediastinal lymph node sampling can be an alternative treatment for aged patients with early peripheral lung cancer.%背景与目的 治疗早期非小细胞肺癌首选手术治疗,但最佳的淋巴结清扫范围仍然不清楚.本研究旨在探讨肺楔形切除+纵隔淋巴结采样治疗在早期高龄肺癌患者中的价值.方法 2004年6月-2008年2月,共有15例70岁以上周围型肺癌患者接受胸腔镜下肺楔形切除术+纵隔淋巴结采样治疗.右侧肺癌行2R、4R、8及9组淋巴结采样,左侧肺癌行5、6、8及9组淋巴结采样.结果 早期高龄肺癌患者行胸腔镜下肺楔形切除术+淋巴结采样,手术时间短、创伤小,术后并发症少,恢复快.术后1年生存率和3年生存率分别为100%和86.6%.结论肺楔形切除术+纵隔淋巴结采样治疗早期高龄周围型肺癌患者是一种选择.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号